top of page
CELLTIUM is redefining Personalized Biotechnology
PRECISION™ Therapeutics: Innovative Scientific Advances
At CELLTIUM, we are driven to excel in the field of biotechnology by developing groundbreaking, first-in-class curative therapies. Our focus encompasses a range of critical neurological disorders, including Charcot-Marie-Tooth disease (CMT), diabetic peripheral neuropathy (DPN), chemotherapy-induced peripheral neuropathy (CIPN), and amyotrophic lateral sclerosis (ALS). Our mission is to transform treatment paradigms in these areas, setting new benchmarks in biotechnological healthcare solutions.
CELLTIUM is seeking for research talent as well as highly-motivated management. Let us know about your brilliant urge to make a real difference.
CELLTIUM is partnering with leading capitalists to further biotech innovations for healthier humanity.
bottom of page